ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 91 filers reported holding ADICET BIO INC in Q1 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $5,492,000 | +14.2% | 275,000 | 0.0% | 0.57% | +3.4% |
Q4 2021 | $4,810,000 | +338.1% | 275,000 | +96.4% | 0.55% | +312.7% |
Q3 2021 | $1,098,000 | -7.2% | 140,000 | +21.7% | 0.13% | -2.2% |
Q2 2021 | $1,183,000 | -9.6% | 115,000 | +15.0% | 0.14% | +2.2% |
Q1 2021 | $1,308,000 | – | 100,000 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 1,615,385 | $20,968,000 | 7.24% |
Consonance Capital Management LP | 1,216,860 | $15,917,000 | 1.70% |
VR Adviser, LLC | 1,000,000 | $13,080,000 | 1.42% |
Johnson & Johnson Innovation - JJDC, Inc. | 728,944 | $9,535,000 | 1.24% |
DAFNA Capital Management LLC | 385,077 | $5,037,000 | 1.20% |
Ally Bridge Group (NY) LLC | 425,000 | $5,559,000 | 1.07% |
Orbimed Advisors | 7,232,856 | $94,606,000 | 0.88% |
Avidity Partners Management LP | 2,230,000 | $29,168,000 | 0.81% |
Altium Capital Management LP | 142,289 | $1,861,000 | 0.52% |
Nantahala Capital Management | 395,875 | $5,178,000 | 0.15% |